Accurate, reliable results play a role in free and fair elections. So does explaining the data and helping people understand ...

Incyte (Nasdaq:INCY) today announced that data from key programs in its oncology portfolio will be presented in both oral and poster sessions at the 2025 American Society of Hematology (ASH) Annual ...

Vertex Pharmaceuticals (VRTX) is rated as a "Strong Buy" due to robust revenue growth and multiple expansion opportunities ...

AI-driven precision-oncology analysis identifies patient subtypes with potential enhanced response to glufosfamide ...

Bio-Techne (TECH) and Nucleai announced the presentation of pivotal data from the SECOMBIT clinical trial at the Society for Immunotherapy of ...

IFF (NYSE: IFF) reported financial results for the third quarter ended September 30, 2025.

Scilex Holding Company ("Scilex" or the "Company") (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing ...

The combined entity revenue exceeds $850 million*, with positive Adjusted EBITDA*, and $920 million* in backlog ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced business updates and reported ...

Thanks to AI, data science tasks that once demanded specialized skills can now be performed faster, more accurately and at a ...

The world of sports is quickly changing, and you can see the change clearly in how teams use data to gain an edge. From ...